Literature DB >> 965096

Relationship of bacteriophages to alpha toxin production in Clostridium novyi types A and B.

M W Eklund, F T Poysky, M E Peterson, J A Meyers.   

Abstract

The relationship of specific bacteriophages to the production of the lethal alpha toxin in Clostridium novyi types A and B was investigated. When type A strain 5771 reverted to the phage-sensitive state, it ceased to produce alpha toxin but continued to produce the gamma and epsilon antigens. This "nontoxigenic" culture, therefore, more closely resembled C. botulinum types C and D than the other C. novyi types. Phage-sensitive type B strains also ceased to produce the alpha toxin but continued to produce the beta toxin, and therefore very colesly resembled C. novyi type D (C. haemolyticum). Alpha toxin was again produced when the phage-sensitive cultures were reinfected with the respective tox+ phages. Alpha toxin production could also be induced in the "nontoxigenic" phage-sensitive derivatives from type B strain 8024 by tox+ phages isolated from other strains of type B. tox- phages were also isolated, but they did not affect alpha toxin production. The tox+ phages also caused a marked change in the colonial morphology of type B strains. In this report we present evidence that alpha toxin production by C. novyi type A strain 5771 and type B strain 8024 depends upon the continued presence and participation of specific bacteriophages designated as NA1tox+ and NB1tox+, respectively.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 965096      PMCID: PMC420955          DOI: 10.1128/iai.14.3.793-803.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  A simple method for the concentration of fluids containing protein.

Authors:  J KOHN
Journal:  Nature       Date:  1959-04-11       Impact factor: 49.962

2.  The soluble antigens of Clostridium oedematiens type D (CI. haemolyticum).

Authors:  C L OAKLEY; G H WARRACK
Journal:  J Pathol Bacteriol       Date:  1959-10

3.  Clostridium oedematiens n-antigen, an enzyme decomposing tropomyosin.

Authors:  M G MACFARLANE
Journal:  Biochem J       Date:  1955-10       Impact factor: 3.857

4.  A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D.

Authors:  M STERNE; L M WENTZEL
Journal:  J Immunol       Date:  1950-08       Impact factor: 5.422

5.  Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage.

Authors:  M W Eklund; F T Poysky; J A Meyers; G A Pelroy
Journal:  Science       Date:  1974-11-01       Impact factor: 47.728

6.  Activation of a toxic component of Clostridium botulinum types C and D by trypsin.

Authors:  M W Eklund; F T Poysky
Journal:  Appl Microbiol       Date:  1972-07

7.  Bacteriophage and the toxigenicity of Clostridium botulinum type D.

Authors:  M W Eklund; F T Poysky; S M Reed
Journal:  Nat New Biol       Date:  1972-01-05

8.  Bacteriophages of Clostridium botulinum.

Authors:  C E Dolman; E Chang
Journal:  Can J Microbiol       Date:  1972-01       Impact factor: 2.419

9.  Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.

Authors:  M W Eklund; F T Poysky
Journal:  Appl Microbiol       Date:  1974-01

10.  RELATIONSHIP BETWEEN TOXIGENICITY AND SPORULATING POTENCY OF CLOSTRIDIUM NOVYI.

Authors:  S NISHIDA; G NAKAGAWARA
Journal:  J Bacteriol       Date:  1965-04       Impact factor: 3.490

View more
  14 in total

Review 1.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

Review 2.  Gas gangrene in mammals: a review.

Authors:  Carlos A Oliveira Junior; Rodrigo O S Silva; Francisco C F Lobato; Mauricio A Navarro; Francisco A Uzal
Journal:  J Vet Diagn Invest       Date:  2020-02-21       Impact factor: 1.279

3.  Combination bacteriolytic therapy for the treatment of experimental tumors.

Authors:  L H Dang; C Bettegowda; D L Huso; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

4.  Identification and characterization of Clostridium sordellii toxin gene regulator.

Authors:  Apoorva Reddy Sirigi Reddy; Brintha Parasumanna Girinathan; Ryan Zapotocny; Revathi Govind
Journal:  J Bacteriol       Date:  2013-07-19       Impact factor: 3.490

5.  An atypical Clostridium strain related to the Clostridium botulinum group III strain isolated from a human blood culture.

Authors:  Philippe Bouvet; Raymond Ruimy; Christiane Bouchier; Nathalie Faucher; Christelle Mazuet; Michel R Popoff
Journal:  J Clin Microbiol       Date:  2013-10-02       Impact factor: 5.948

6.  Plasmidome interchange between Clostridium botulinum, Clostridium novyi and Clostridium haemolyticum converts strains of independent lineages into distinctly different pathogens.

Authors:  Hanna Skarin; Bo Segerman
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

7.  The complexity and diversity of the Pathogenicity Locus in Clostridium difficile clade 5.

Authors:  Briony Elliott; Kate E Dingle; Xavier Didelot; Derrick W Crook; Thomas V Riley
Journal:  Genome Biol Evol       Date:  2014-11-08       Impact factor: 3.416

Review 8.  Vaccine Production to Protect Animals Against Pathogenic Clostridia.

Authors:  Nicolas E Zaragoza; Camila A Orellana; Glenn A Moonen; George Moutafis; Esteban Marcellin
Journal:  Toxins (Basel)       Date:  2019-09-11       Impact factor: 4.546

Review 9.  Large Clostridial Toxins: Mechanisms and Roles in Disease.

Authors:  Kathleen E Orrell; Roman A Melnyk
Journal:  Microbiol Mol Biol Rev       Date:  2021-06-02       Impact factor: 13.044

10.  Clostridium sordellii Pathogenicity Locus Plasmid pCS1-1 Encodes a Novel Clostridial Conjugation Locus.

Authors:  Milena Awad; Dena Lyras; Callum J Vidor; Thomas D Watts; Vicki Adams; Dieter Bulach; Edward Couchman; Julian I Rood; Neil F Fairweather
Journal:  MBio       Date:  2018-01-16       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.